Nottingham University Hospitals NHS Trust, UK.
Ann R Coll Surg Engl. 2021 Apr;103(4):285-290. doi: 10.1308/rcsann.2020.7133. Epub 2021 Mar 8.
Necrotising otitis externa (NOE) is a severe infection of the temporal bone. The traditional severity based staging system does not fully prognosticate all patients with NOE. We hypothesise that a patient response staging system would more accurately capture the disease process and guide prognosis.
We carried out a retrospective notes review of patients diagnosed with NOE from January 2017 to December 2018 in a regional tertiary referral centre. Patient outcomes from our proposed patient response staging system were compared to a modified previously published severity based Gleeson staging system with patients requiring prolonged treatment classified as having a poor outcome.
A total of 34 patients were treated for NOE. The majority were male (=24) and had diabetes (=25). Patients with the most severe Gleeson staging did not have the worst outcome. Daily delay in resolution of otorrhoea was associated with an increased need for more than six weeks of treatment. Rapid responders are patients who had resolution of otalgia, otorrhoea and C-reactive protein normalisation within 14 days, and all were cured following standard 6 weeks of treatment.
The Gleeson staging system was valuable in assessing the extent of disease and all early Gleeson staged patients had good outcomes. However, patients with higher severity staging on the Gleeson system did not necessarily require prolonged treatment. There is a role for a joint approach in staging patients based on both modified Gleeson and treatment response, which would subsequently guide prognosis, duration of treatment and early diagnosis of potential fungal NOE.
坏死性外耳道炎(NOE)是一种严重的颞骨感染。传统的基于严重程度的分期系统并不能完全预测所有患有 NOE 的患者。我们假设患者反应分期系统将更准确地捕捉疾病过程并指导预后。
我们对 2017 年 1 月至 2018 年 12 月在一个区域三级转诊中心诊断为 NOE 的患者进行了回顾性病历回顾。我们提出的患者反应分期系统的患者结局与改良的先前发表的基于 Gleeson 严重程度的分期系统进行了比较,需要延长治疗的患者被归类为预后不良。
共有 34 例患者接受了 NOE 的治疗。大多数是男性(=24),患有糖尿病(=25)。Gleeson 分期最严重的患者并未出现最差结局。耳漏缓解的每日延迟与需要超过六周的治疗的可能性增加相关。快速反应者是指在 14 天内疼痛、耳漏和 C 反应蛋白正常化的患者,所有患者在标准 6 周治疗后均治愈。
Gleeson 分期系统在评估疾病程度方面具有价值,所有早期 Gleeson 分期患者均有良好结局。然而,Gleeson 系统上严重程度分期较高的患者不一定需要延长治疗。根据改良的 Gleeson 和治疗反应联合对患者进行分期的方法具有一定作用,这将有助于预测预后、治疗持续时间以及潜在真菌性 NOE 的早期诊断。